Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer
Said Furkan Yildirim, Pervin Demir, Hakan Kosku, Bulent Yalcin, Ahmet Cevdet Ceylan
Springer Nature ·
2026-09-25
· DOI 10.1007/s12282-026-01913-9
The publisher did not provide an abstract — full text is available via the link below.
Said Furkan Yildirim, Pervin Demir, Hakan Kosku, Bulent Yalcin, Ahmet Cevdet Ceylan. Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. // Breast Cancer. – 2026. – DOI: 10.1007/s12282-026-01913-9. – URL: https://doi.org/10.1007/s12282-026-01913-9
Said Furkan Yildirim, Pervin Demir, Hakan Kosku, Bulent Yalcin, & Ahmet Cevdet Ceylan (2026). Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. Breast Cancer. https://doi.org/10.1007/s12282-026-01913-9
Said Furkan Yildirim, et al. “Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer.” Breast Cancer, 2026. doi:10.1007/s12282-026-01913-9.
@article{Yildirim2026,
title = {Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer},
author = {Yildirim, Said Furkan and Demir, Pervin and Kosku, Hakan and Yalcin, Bulent and Ceylan, Ahmet Cevdet},
journal = {Breast Cancer},
year = {2026},
doi = {10.1007/s12282-026-01913-9},
url = {https://doi.org/10.1007/s12282-026-01913-9}
}